These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. IV artesunate for severe malaria. Med Lett Drugs Ther; 2008 May; 50(1286):37. PubMed ID: 18487956 [No Abstract] [Full Text] [Related]
5. Artemether for severe malaria: a meta-analysis of randomized clinical trials. Pittler MH; Ernst E Clin Infect Dis; 1999 Mar; 28(3):597-601. PubMed ID: 10194084 [TBL] [Abstract][Full Text] [Related]
6. The treatment of severe malaria. Dondorp AM; Day NP Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):633-4. PubMed ID: 17434195 [TBL] [Abstract][Full Text] [Related]
7. Intravenous artesunate for severe malaria. Prescrire Int; 2008 Aug; 17(96):168-70. PubMed ID: 19492495 [TBL] [Abstract][Full Text] [Related]
8. Artesunate, artemether or quinine in severe Plasmodium falciparum malaria? Checkley AM; Whitty CJ Expert Rev Anti Infect Ther; 2007 Apr; 5(2):199-204. PubMed ID: 17402835 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance. Nyunt MM; Plowe CV Clin Pharmacol Ther; 2007 Nov; 82(5):601-5. PubMed ID: 17898709 [TBL] [Abstract][Full Text] [Related]
10. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Noedl H; Krudsood S; Chalermratana K; Silachamroon U; Leowattana W; Tangpukdee N; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Sriwichai S; Rowan J; Bhattacharyya H; Ohrt C; Knirsch C Clin Infect Dis; 2006 Nov; 43(10):1264-71. PubMed ID: 17051490 [TBL] [Abstract][Full Text] [Related]
11. Artesunate. The standard intravenous treatment for severe attacks of malaria. Prescrire Int; 2014 Nov; 23(154):260. PubMed ID: 25954791 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of artesunate for the treatment of severe malaria. Lubell Y; Yeung S; Dondorp AM; Day NP; Nosten F; Tjitra E; Abul Faiz M; Yunus EB; Anstey NM; Mishra SK; Mohanty S; White NJ; Mills AJ Trop Med Int Health; 2009 Mar; 14(3):332-7. PubMed ID: 19187518 [TBL] [Abstract][Full Text] [Related]
13. [ASAQ, a breakthrough in the fight against malaria]. Kiechel JR; Pécoul B Med Trop (Mars); 2007 Apr; 67(2):109-10. PubMed ID: 17691424 [No Abstract] [Full Text] [Related]
14. The role of the qinghaosu derivatives in the treatment of severe malaria. Boele van Hensbroek M Med Trop (Mars); 1998; 58(3 Suppl):59-60. PubMed ID: 10212901 [TBL] [Abstract][Full Text] [Related]
16. [Management of children severe malaria in Tsévié's (Togo) hospital regional center]. Djadou KE; Komlangan A; Balaka B; Dokounor D; Gbadoé AD; Atakouma D; Agbèrè AD; Kessié K; Assimadi K Arch Pediatr; 2006 Dec; 13(12):1555-6. PubMed ID: 17046219 [No Abstract] [Full Text] [Related]
17. Artesunate for severe malaria. Lancet; 2011 Apr; 377(9776):1466. PubMed ID: 21531257 [No Abstract] [Full Text] [Related]
18. Malaria. "One step forward, two steps back". Rees PH East Afr Med J; 2006 May; 83(5):233-5. PubMed ID: 16866216 [No Abstract] [Full Text] [Related]
19. Chemotherapeutic agents against malaria: what next after chloroquine? Domínguez JN Curr Top Med Chem; 2002 Nov; 2(11):1173-85. PubMed ID: 12171580 [TBL] [Abstract][Full Text] [Related]
20. Clinical presentation and outcome of severe malaria in adults in Zaria, Northern Nigeria. Ogoina D; Obiako RO Ann Afr Med; 2012; 11(4):245-6. PubMed ID: 23103926 [No Abstract] [Full Text] [Related] [Next] [New Search]